Amgen Safety Net Foundation
Amgen Safety Net Foundation (ASNF) is a nonprofit patient assistance program that helps patients with financial need gain access to Amgen medicines at no cost.
Stats
Alexa Rank:
Popular in Country:
Country Alexa Rank:
language: en
Response Time: 0.816523
SSL: Enable
Status: up
Code To Txt Ratio
Word Count 178
Links
ratio 24.619621653348
SSL Details
SSL Issuer:
Issuer: Sectigo RSA Organization Validation Secure Server CA
Valid From: 2022-04-06 00:00:00
Expiration Date: 2023-04-06 23:59:59
SSL Organization:
Signature 586607d01c0cf8cceb3a4e69a0e1909261844fb3
Algorithm: RSA-SHA256
Found 77 Top Alternative to Amgensafetynetfoundation.com
54.88.190.19
United States
Valid SSL
Amgenassist360.com
Amgen Assist 360 Assistance
Welcome to the Amgen Assist 360™ website, which provides information on access and assistance for Amgen treatments, as well as helpful tools and resources.
Repathahcp.com
Reduce Risk of MI & Stroke in CVD Patients | Repatha® (evolocumab)
Learn about PCSK9 inhibitor Repatha® (evolocumab) and how it reduces risk of stroke and myocardial infarction in your patients with established CV disease
Sensipar.com
Secondary hyperparathyroidism (HPT) treatment for patients with chronic kidney disease | Sensipar® (cinacalcet)
CLOSE SEE MORE + CLOSE – Important Safety Information Do not use Sensipar® (cinacalcet) if you have low calcium levels. Ask your healthcare provider about the normal ranges. Low calcium levels: Sensipar® lowers calcium and can lead to low calcium levels in your blood. Tell your healthcare provider if you...
Amgenoncology.com
Advancing Oncology at the Speed of Life | Amgen Oncology
At Amgen we are committed to changing the course of cancer treatment for more than 40 years. Learn about all of the different Amgen Oncology web propoerties and resources that Amgen has to offer.
Proliahcp.com
Osteoporosis Patients at High Risk | Prolia® (denosumab)
Learn about a treatment indicated for women with postmenopausal osteoporosis and men with osteoporosis at high risk for fracture. See Full Prescribing & Safety Info.
Prolia.com
Prolia® (denosumab) | Postmenopausal Osteoporosis Treatment®
Life is full of make or break moments. Are your bones strong? Learn more about Prolia® (denosumab).
Rxassist.org
RxAssist - Patient Assistance Programs
Health Care Professionals Helping You Help Your Patients Help your patients obtain free or low-cost medications and learn more about safety net programs for the uninsured. The Web's most current and comprehensive directory of Patient Assistance Programs Patient assistance programs are run by pharmaceutical companies to provide free...
Amgen.com
Amgen | A Worldwide Pioneer in Biotechnology
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Amgeniss.com
ISS home page
Bone Product: Evenity® (romosozumab) Areas of Research Interest Advancing the understanding of the burden of fragility fractures Advancing the understanding of sclerostin biology Advancing the understanding of EVENITY in approved indications Studying EVENITY in situations of high unmet need Product: Prolia® (denosumab) Areas of Research Interest Please go to Product:...
Addingprolia.com
Prolia® (denosumab)
X Indications What is Prolia®? Prolia® is a prescription medicine used to: Treat bone loss in men who are at high risk for fracture receiving certain treatments for prostate cancer that has not spread to . . . Read MoreRead More other parts of the body. Treat bone loss in women who...
Amgenbiotechexperience.com
Home | Amgen Biotech Experience
ABE empowers teachers to bring biotechnology to their classrooms. Curriculum & Resources Amgen Biotech Experience (ABE) offers many types of curricula and resources. View all Lab-based Investigations Students to learn about core technologies used by scientists in the discovery of human therapeutics, so that they will better understand the role...
Alpha-create.ne.jp
アルファクリエイト株式会社｜Webサイト制作・デザイン｜大阪 東京 岡山
大阪・東京・岡山を拠点に活動するWeb・ホームページ制作会社です。「デザインの力で企業を変える」を企業理念に、Webデザイン制作から運用、改善、マーケティング戦略、プロモーション動画制作まで、Web戦略をトータルプランニングしております。
Pparx.org
Medicine Assistance Tool
PhRMA’s Medicine Assistance Tool (MAT) helps patients, caregivers and health care providers find information about financial assistance and other resources made available through various biopharmaceutical industry programs. As a specialized search engine, MAT provides a single point of access to information about hundreds of public and private assistance programs that may be able to help those with financial need get access to their prescriptions. MAT is not a patient assistance program itself, but instead is a search tool used to find such programs.
Scbn.org
Help With Prescription Medications through Patient Assistance Programs
Help with Medications is Available. Patient Assistance Programs give free prescription drugs to those in need. These free prescription drugs often require a prescription advocate to receive ongoing prescription help.
Technologies Used by amgensafetynetfoundation.com
Dns Records of amgensafetynetfoundation.com
A Record: 34.210.146.128 54.213.68.106AAAA Record:
CNAME Record:
NS Record: ns-481.awsdns-60.com ns-1856.awsdns-40.co.uk ns-1341.awsdns-39.org ns-587.awsdns-09.net
SOA Record: awsdns-hostmaster.amazon.com
MX Record: amgen-com.mail.protection.outlook.com
SRV Record:
TXT Record:
DNSKEY Record:
CAA Record:
Whois Detail of amgensafetynetfoundation.com
Domain Name: AMGENSAFETYNETFOUNDATION.COMRegistry Domain ID: 610852131_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.markmonitor.com
Registrar URL: http://www.markmonitor.com
Updated Date: 2020-08-27T09:12:31Z
Creation Date: 2006-09-28T00:22:22Z
Registry Expiry Date: 2022-09-28T00:22:22Z
Registrar: MarkMonitor Inc.
Registrar IANA ID: 292
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +1.2086851750
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS-1341.AWSDNS-39.ORG
Name Server: NS-1856.AWSDNS-40.CO.UK
Name Server: NS-481.AWSDNS-60.COM
Name Server: NS-587.AWSDNS-09.NET
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2022-06-26T18:13:19Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.